Is Pot Stock GW Pharmaceuticals Undervalued?

GW Pharmaceuticals NASDAQ GWPH is on the cusp of shaking up the U S epilepsy treatment market The medical marijuana company won FDA approval for Epidiolex s use in rare childhood onset epilepsy over the summer and it should become commercially available to patients as soon as

Source

The post Is Pot Stock GW Pharmaceuticals Undervalued? appeared first on Cannabis Stock Picks.

Go to OG News Source
Author: Admin
{authorlink}